Clinical trial
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients…
NCT00005590 · Cancer Research Campaign Clinical Trials Centre, Other · Completed
Key facts
| NCT number | NCT00005590 |
|---|---|
| Title | Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma |
| Official title | A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors |
| Lead sponsor | Cancer Research Campaign Clinical Trials Centre, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Breast Cancer, Extragonadal Germ Cell Tumor, Infection, Lung Cancer, Lymphoma, Ovarian Cancer, Small Intestine Cancer, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor and 1 more |
| Intervention type | Drug |
| Interventions | levofloxacin |
| Start date | Aug 1, 1999 |
| Completion | Sep 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 2, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: